CompareMarketResearchRequest a sample
Home / Healthcare / AI-Driven Cardiac Diagnostics

Healthcare · Market report

AI-Driven Cardiac Diagnostics Market Size, Share and Forecast 2026-2036

The global AI-driven cardiac diagnostics market is worth USD 1.3 bn in 2026 and is forecast to reach USD 5.9 bn by 2036, growing at a 16.0% CAGR. United States is the largest country market and AI-ECG and wearables is the largest by modality segment.

USD 1.3 bnMarket size 2026
USD 5.9 bnForecast 2036
16.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global AI-driven cardiac diagnostics market is worth USD 1.3 bn in 2026 and is forecast to reach USD 5.9 bn by 2036, growing at a 16.0% CAGR. United States is the largest country market and AI-ECG and wearables is the largest by modality segment.

ScopeAI software that interprets ECG, echocardiography, cardiac CT and MRI data to detect and quantify heart disease, including plaque analysis and AI-guided physiology, sold to hospitals, clinics and remote monitoring services.
IndustryHealthcare
Value 2025USD 1.1 bn
Value 2026USD 1.3 bn
Value 2036USD 5.9 bn
CAGR 2026-203616.0%
Volume 202630.4 million analyses
Volume 2036134 million analyses
Average price 2026USD 44.2 per analyse
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

AI-Driven Cardiac Diagnostics market size and forecast, 2026-2036

Exhibit 1The global AI-driven cardiac diagnostics market is forecast to grow from USD 1.3 bn in 2026 to USD 5.9 bn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 16.0%
AI-Driven Cardiac Diagnostics market value, 2025 to 2036Market value by year. 2025: USD 1.1 bn; 2026: USD 1.3 bn; 2027: USD 1.6 bn; 2028: USD 1.8 bn; 2029: USD 2.1 bn; 2030: USD 2.4 bn; 2031: USD 2.8 bn; 2032: USD 3.3 bn; 2033: USD 3.8 bn; 2034: USD 4.4 bn; 2035: USD 5.1 bn; 2036: USD 5.9 bn. Compound annual growth rate 2026 to 2036: 16.0%.20251.3 bn20262.8 bn20315.9 bn203616.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 1.3 bn
2027USD 1.6 bn
2028USD 1.8 bn
2029USD 2.1 bn
2030USD 2.4 bn
2031USD 2.8 bn
2032USD 3.3 bn
2033USD 3.8 bn
2034USD 4.4 bn
2035USD 5.1 bn
2036USD 5.9 bn

AI-Driven Cardiac Diagnostics market segmentation

By modality

Exhibit 2AI-ECG and wearables is the largest segment by modality, with 38.0% of 2026 revenueEstimated share of 2026 global revenue, by modality
AI-Driven Cardiac Diagnostics market share by modality, 2026Share of 2026 revenue by modality. AI-ECG and wearables: 38.0%; Cardiac CT and plaque analysis: 28.0%; AI echocardiography: 22.0%; Cardiac MRI and nuclear analytics: 12.0%.AI-ECG and wearables38.0%Cardiac CT and plaque analysis28.0%AI echocardiography22.0%Cardiac MRI and nuclear analytics12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
AI-ECG and wearables38.0%40.1%USD 511 mn16.6%
AI echocardiography22.0%21.3%USD 296 mn15.6%
Cardiac CT and plaque analysis28.0%29.6%USD 377 mn16.6%
Cardiac MRI and nuclear analytics12.0%9.0%USD 161 mn12.7%

By care setting

Exhibit 3Hospitals adds the most revenue by care setting, growing from USD 780 mn in 2026 to USD 2.9 bn by 2036Estimated revenue in USD by care setting, 2026 and 2036 forecast
AI-Driven Cardiac Diagnostics market by care setting, 2026 and 2036Revenue by care setting in 2026 and 2036. Hospitals: USD 780 mn in 2026, USD 2.9 bn in 2036, change +266%; Home and remote monitoring: USD 269 mn in 2026, USD 1.8 bn in 2036, change +565%; Ambulatory clinics: USD 296 mn in 2026, USD 1.3 bn in 2036, change +336%.20262036 forecastChangeHospitals+266%780 mn2.9 bnHome and remote monitoring+565%269 mn1.8 bnAmbulatory clinics+336%296 mn1.3 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals58.0%48.1%USD 780 mn13.9%
Ambulatory clinics22.0%21.7%USD 296 mn15.9%
Home and remote monitoring20.0%30.1%USD 269 mn20.9%

By clinical task

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Detection and screening38.0%37.0%USD 511 mn15.7%
Quantification and measurement28.0%28.0%USD 377 mn16.0%
Risk prediction20.0%22.0%USD 269 mn17.1%
Reporting and workflow14.0%13.0%USD 188 mn15.1%

By condition

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Coronary artery disease30.0%30.0%USD 404 mn16.0%
Heart failure24.0%26.0%USD 323 mn16.9%
Arrhythmia28.0%28.0%USD 377 mn16.0%
Valve and structural disease18.0%16.0%USD 242 mn14.6%

By deployment

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cloud50.0%55.0%USD 673 mn17.1%
On-premise32.0%27.0%USD 431 mn14.1%
Edge and device-embedded18.0%18.0%USD 242 mn16.0%

Top 25 countries for AI-driven cardiac diagnostics by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.0% of 2026 revenue and the 25 countries below together hold 96.7%.

Exhibit 4United States is the largest country market at USD 592 mn in 2026, and the three largest countries hold 61.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
AI-Driven Cardiac Diagnostics market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 592 mn, 44.0%; China: USD 148 mn, 11.0%; Germany: USD 81 mn, 6.0%; Japan: USD 81 mn, 6.0%; United Kingdom: USD 67 mn, 5.0%; France: USD 54 mn, 4.0%; India: USD 40 mn, 3.0%; Italy: USD 40 mn, 3.0%; Canada: USD 40 mn, 3.0%; Australia: USD 27 mn, 2.0%.United States592 mn 44.0%China148 mn 11.0%Germany81 mn 6.0%Japan81 mn 6.0%United Kingdom67 mn 5.0%France54 mn 4.0%India40 mn 3.0%Italy40 mn 3.0%Canada40 mn 3.0%Australia27 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 592 mn44.0%USD 2.6 bn15.9%
2ChinaUSD 148 mn11.0%USD 772 mn17.9%
3GermanyUSD 81 mn6.0%USD 326 mn15.0%
4JapanUSD 81 mn6.0%USD 309 mn14.3%
5United KingdomUSD 67 mn5.0%USD 285 mn15.5%
6FranceUSD 54 mn4.0%USD 214 mn14.8%
7IndiaUSD 40 mn3.0%USD 226 mn18.8%
8ItalyUSD 40 mn3.0%USD 154 mn14.3%
9CanadaUSD 40 mn3.0%USD 172 mn15.6%
10AustraliaUSD 27 mn2.0%USD 119 mn16.0%
11SpainUSD 14 mn1.0%USD 55 mn15.1%
12South KoreaUSD 14 mn1.0%USD 62 mn16.4%
13NetherlandsUSD 11 mn0.8%USD 45 mn15.0%
14SwitzerlandUSD 10.0 mn0.7%USD 40 mn15.0%
15SwedenUSD 10.0 mn0.7%USD 40 mn15.0%
16BelgiumUSD 8.8 mn0.7%USD 35 mn14.9%
17BrazilUSD 8.8 mn0.7%USD 44 mn17.5%
18TaiwanUSD 8.8 mn0.7%USD 40 mn16.4%
19IsraelUSD 7.4 mn0.6%USD 34 mn16.4%
20DenmarkUSD 7.4 mn0.6%USD 30 mn15.1%
21AustriaUSD 6.2 mn0.5%USD 25 mn14.9%
22PolandUSD 6.2 mn0.5%USD 28 mn16.5%
23TurkeyUSD 6.2 mn0.5%USD 31 mn17.6%
24SingaporeUSD 6.2 mn0.5%USD 28 mn16.5%
25Saudi ArabiaUSD 6.2 mn0.5%USD 31 mn17.6%
Rest of worldUSD 45 mn3.3%USD 195 mn15.9%
Exhibit 5United States and China account for 57% of the USD 4.6 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
AI-Driven Cardiac Diagnostics market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 1.3 bn. United States: +USD 2.0 bn; China: +USD 624 mn; Germany: +USD 246 mn; Japan: +USD 228 mn; United Kingdom: +USD 218 mn; 20 other countries: +USD 1.1 bn; Rest of world: +USD 150 mn. Market value 2036: USD 5.9 bn.Market value 20261.3 bnUnited States+2.0 bnChina+624 mnGermany+246 mnJapan+228 mnUnited Kingdom+218 mn20 other countries+1.1 bnRest of world+150 mnMarket value 20365.9 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Philips
  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems
  • Baxter International

Group 2: Regional and specialist players

  • HeartFlow
  • Cleerly
  • iRhythm Technologies
  • Eko Health
  • Us2.ai
  • AliveCor
  • Idoven
  • Tempus AI
  • Circle Cardiovascular Imaging
  • Elucid

Group 3: Emerging and niche players

  • Ultromics
  • Caristo Diagnostics
  • Anumana
  • Powerful Medical
  • Heart Test Laboratories

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the AI-driven cardiac diagnostics market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 16.0% is calculated from the resulting values.

The market is divided by modality, by care setting, by clinical task, by condition, by deployment. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the AI-driven cardiac diagnostics market?

The global AI-driven cardiac diagnostics market is estimated at USD 1.1 bn in 2025 and USD 1.3 bn in 2026.

How fast will the AI-driven cardiac diagnostics market grow?

It is forecast to reach USD 5.9 bn by 2036, a compound annual growth rate of 16.0% from 2026, an increase of USD 4.6 bn.

Which country is the largest market for AI-driven cardiac diagnostics?

United States is the largest market by revenue at USD 592 mn in 2026, 44.0% of the global total. The three largest countries together hold 61.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 18.8% a year from 2026 to 2036.

Which AI-driven cardiac diagnostics segment is largest?

In the by modality split, AI-ECG and wearables is the largest segment with 38.0% of 2026 revenue.

Who are the leading AI-driven cardiac diagnostics companies?

Global leaders include Philips, GE HealthCare, Siemens Healthineers, Canon Medical Systems.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← AI-Assisted Clinical Trial Protocol Design AI-Powered Behavioral Therapy →

All Healthcare markets →

Request a sample